APA (7th ed.) Citation

Li, Y., & Wang, G. (2025). Primary Endpoint and Analysis Model for Prevention Trials with Participants with Preclinical AD: Lessons Learned from the DIAN‐TU Platform Trial. Alzheimer's & dementia: the journal of the Alzheimer's Association, 21(S5), 1. https://doi.org/10.1002/alz70859_099564

Chicago Style (17th ed.) Citation

Li, Yan, and Guoqiao Wang. "Primary Endpoint and Analysis Model for Prevention Trials with Participants with Preclinical AD: Lessons Learned from the DIAN‐TU Platform Trial." Alzheimer's & Dementia: The Journal of the Alzheimer's Association 21, no. S5 (2025): 1. https://doi.org/10.1002/alz70859_099564.

MLA (9th ed.) Citation

Li, Yan, and Guoqiao Wang. "Primary Endpoint and Analysis Model for Prevention Trials with Participants with Preclinical AD: Lessons Learned from the DIAN‐TU Platform Trial." Alzheimer's & Dementia: The Journal of the Alzheimer's Association, vol. 21, no. S5, 2025, p. 1, https://doi.org/10.1002/alz70859_099564.